Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

A new genetic mutation in the hairless gene causes a rare hair loss disorder.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ritlecitinib can help about 14,000 people with severe hair loss.

Higher adrenaline and prolactin levels may indicate stress-related alopecia areata in adults.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

TNF-a may not be as involved in certain types of hair loss as previously thought.

JAK inhibitors may help improve symptoms in adults with APECED.

Alopecia areata may be caused by the immune system attacking hair follicles.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Ruxolitinib helped a patient with alopecia areata regrow hair.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

The role of γδT-cells in causing alopecia areata remains unclear.